Company Analysis
Sign in

Avalo Therapeutics, Inc. (AVTX)

Nasdaq: AVTX · Pharmaceutical Preparations · Wayne, PA · filing with the SEC since 2012
Full chart Alerts Compare
Grade2.6
◀ Past 1.6● Present 2.6▶ Future 3.3
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

24 patents granted to the 6 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Avalo Therapeutics, Inc.’s names, not what it holds today.

Patents granted
24
24 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against none in 2024 and 1 in 2023
Applications published
29
1 of them in 2025
Names they are printed under
6
a subsidiary, its own name, a former name
By yearGrantedApplications published
'13'14'15'16'17'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals5
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name6 counted
Medgenics Medical Israel Ltd. a subsidiary
IL, as the owner printed on each patent
14 granted
13 published
AVALO THERAPEUTICS, INC. its own name
US, as the owner printed on each patent
4 granted
6 published
CERECOR, INC. a former name
US, as the owner printed on each patent
6 granted
3 published
CERECOR, INC. a former name
named as the applicant on its applications, in US
0 granted
5 published
Avalo Therapeutics, Inc. its own name
named as the applicant on its applications, in US
0 granted
1 published
Medgenics Medical Israel Ltd. a subsidiary
named as the applicant on its applications, in IL
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Sep 9, 202512,410,153Compounds, compositions and methodsPharmaceuticalsAVALO THERAPEUTICS, INC.
Jun 17, 202512,331,107Methods of treating pneumonia or respiratory failure associated with COVID-19 by administering an anti-LIGHT antibodyPharmaceuticalsAVALO THERAPEUTICS, INC.
Jul 25, 202311,708,406Method of treating acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) associate with COVID-19 by administering an anti-LIGHT antibodyPharmaceuticalsAVALO THERAPEUTICS, INC.
Oct 25, 202211,479,576Nucleic acid prodrugsPharmaceuticalsAVALO THERAPEUTICS, INC.
Oct 25, 202211,479,542Compounds, compositions and methodsPharmaceuticalsCERECOR, INC.
Aug 18, 202010,745,435Nucleic acid prodrugsPharmaceuticalsCERECOR, INC.
Jul 14, 202010,710,976Compounds, compositions and methodsPharmaceuticalsCERECOR, INC.
Apr 2, 201910,245,396Inhalation devices and systems and methods including the sameMedical technologyCERECOR, INC.
Feb 12, 201910,202,363Compounds, compositions and methodsPharmaceuticalsCERECOR, INC.
Jun 27, 20179,687,564Long lasting drug formulationsPharmaceuticalsMedgenics Medical Israel Ltd.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Jan 2, 20252025/0002598Methods of Treating Asthma with Anti-LIGHT AntibodiesPharmaceuticalsAVALO THERAPEUTICS, INC.
May 16, 20242024/0158522Methods of Treating Ulcerative Colitis with Anti-LIGHT AntibodiesPharmaceuticalsAVALO THERAPEUTICS, INC.
Jan 4, 20242024/0002492METHODS AND TREATMENT INVOLVING EXCESS FREE LIGHTPharmaceuticalsAVALO THERAPEUTICS, INC. · patent 12,331,107 granted from it
Nov 30, 20232023/0381190Methods and Treatment for Complex Lymphatic MalformationsPharmaceuticalsAVALO THERAPEUTICS, INC.
Sep 7, 20232023/0279095Methods and Treatment for Adult-Onset Still's Disease and Systemic-Onset Juvenile Idiopathic Arthritis Involving Antibodies to IL-18PharmaceuticalsAVALO THERAPEUTICS, INC.
Aug 17, 20232023/0257363COMPOUNDS, COMPOSITIONS AND METHODSPharmaceuticalsAvalo Therapeutics, Inc. · patent 12,410,153 granted from it
Jun 29, 20232023/0203150Methods and Treatment Involving Antibodies to IL-18PharmaceuticalsAVALO THERAPEUTICS, INC.
Jun 2, 20222022/0168301METHODS FOR TREATING SYMPTOMATIC ORTHOSTATIC HYPOTENSIONPharmaceuticalsCERECOR, INC.
May 13, 20212021/0139525NUCLEOTIDE PRODRUGSPharmaceuticalsCERECOR, INC.
Apr 15, 20212021/0107892COMPOUNDS, COMPOSITIONS AND METHODSPharmaceuticalsCERECOR, INC. · patent 11,479,542 granted from it
What it applied for, 2024 to 2025: Pharmaceuticals 3.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton AVTX · research, not advice